Master pathways and targets in T cell acute lymphoblastic leukaemia
24 May 2019
Master pathways and targets in T cell acute lymphoblastic leukaemia
Colorectal cancer in the young: What do we know and what can we do?
Using genetic testing to tailor chemotherapy
Providing safe care to hereditary cancer patients and families
The Brain Tumour Charity
How the WIN consortium achieves its goals
The translational element of the WIN consortium
Making oncology global with the WIN consortium
An overview of the WIN consortium
The WIN symposium 2019
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC
Entrectinib in NTRK fusion-positive non-small cell lung cancer